BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8008976)

  • 1. Characterization of and the influence of calcium channel blockers on the renal excretion of pyrimidine anticancer agents.
    Enigbokan MA; Preston J; Hubbard C; Thompson JO
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):270-8. PubMed ID: 8008976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calmodulin inhibitors and calcium channel blockers influence dideoxycytidine renal excretion.
    Enigbokan MA; West D; Preston J; Thompson JO
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S15-8. PubMed ID: 8574143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal transepithelial transport of nucleosides.
    Nelson JA; Vidale E; Enigbokan M
    Drug Metab Dispos; 1988; 16(6):789-92. PubMed ID: 2907454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover.
    Masereeuw R; Moons MM; Toomey BH; Russel FG; Miller DS
    J Pharmacol Exp Ther; 1999 May; 289(2):1104-11. PubMed ID: 10215693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of organic anion and cation transporters in renal excretion of xanthine derivatives, 3-methylxanthine and enprofylline.
    Nadai M; Kato M; Yoshizumi H; Kimura M; Kurono S; Abe F; Saito H; Hasegawa T
    Life Sci; 2007 Sep; 81(15):1175-82. PubMed ID: 17897683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal drug transport: a review.
    Bendayan R
    Pharmacotherapy; 1996; 16(6):971-85. PubMed ID: 8947968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Important role of the dihydrouracil/uracil ratio in marked interpatient variations of fluoropyrimidine pharmacokinetics and pharmacodynamics.
    Jiang H; Lu J; Jiang J; Hu P
    J Clin Pharmacol; 2004 Nov; 44(11):1260-72. PubMed ID: 15496644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P-glycoprotein in renal tubular secretion of digoxin in the isolated perfused rat kidney.
    Hori R; Okamura N; Aiba T; Tanigawara Y
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1620-5. PubMed ID: 8103798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine/organic cation transporter OCTN2 (Slc22a5) is responsible for renal secretion of cephaloridine in mice.
    Kano T; Kato Y; Ito K; Ogihara T; Kubo Y; Tsuji A
    Drug Metab Dispos; 2009 May; 37(5):1009-16. PubMed ID: 19220985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary elimination and metabolism of 5-fluoro-2'-deoxyuridine in isolated perfused rat lung and lung slices.
    Foth H; Hellkamp J; Kunellis EM; Kahl GF
    Drug Metab Dispos; 1990; 18(6):1011-7. PubMed ID: 1981506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins.
    Nijenhuis T; Renkema KY; Hoenderop JG; Bindels RJ
    J Am Soc Nephrol; 2006 Mar; 17(3):617-26. PubMed ID: 16421227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine and probenecid on pilsicainide renal clearance in humans.
    Shiga T; Hashiguchi M; Urae A; Kasanuki H; Rikihisa T
    Clin Pharmacol Ther; 2000 Mar; 67(3):222-8. PubMed ID: 10741624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the renal secretion of cisplatin.
    Nelson JA; Santos G; Herbert BH
    Cancer Treat Rep; 1984 Jun; 68(6):849-53. PubMed ID: 6539649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and calcium receptors: links to hypercalciuria.
    Bai S; Favus MJ
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):381-5. PubMed ID: 16775452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of probenecid and cimetidine on the renal excretion of 3'-azido-3'-deoxythymidine in rats.
    Aiba T; Sakurai Y; Tsukada S; Koizumi T
    J Pharmacol Exp Ther; 1995 Jan; 272(1):94-9. PubMed ID: 7815370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of dipyridamole, a nucleoside transport inhibitor, with the renal transport of organic cations by LLCPK1 cells.
    Bendayan R
    Can J Physiol Pharmacol; 1997 Jan; 75(1):52-6. PubMed ID: 9101065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of three types of calcium channel in the luminal membrane of the distal nephron.
    Brunette MG; Leclerc M; Couchourel D; Mailloux J; Bourgeois Y
    Can J Physiol Pharmacol; 2004 Jan; 82(1):30-7. PubMed ID: 15052303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced glucose absorption in the rat small intestine following repeated doses of 5-fluorouracil.
    Tomimatsu T; Horie T
    Chem Biol Interact; 2005 Aug; 155(3):129-39. PubMed ID: 15996645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle.
    Mosseri M; Fingert HJ; Varticovski L; Chokshi S; Isner JM
    Cancer Res; 1993 Jul; 53(13):3028-33. PubMed ID: 8391384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.